Edgewise Therapeutics EWTX
NASDAQ EWTX
$40.47 -0.13 (-0.32%)
As of: Oct 1, 2026 · 10:25 AM EDT

Edgewise Therapeutics (EWTX) Other Non-Current Liabilities (2021 - 2022)

Updated

Edgewise Therapeutics' Other Non-Current Liabilities was $192,000 in Q2 2022, up 2.7% from the prior quarter.

Analysis

Edgewise Therapeutics (EWTX) Other Non-Current Liabilities (2021 - 2022) Analysis & Trends

At the end of FY2021, Other Non-Current Liabilities at Edgewise Therapeutics came in at $329,000.

  • Quarterly Other Non-Current Liabilities has moved between $187,000 (Q1 2022) and $329,000 (Q4 2021) over five years.
  • Per Business Quant data, EWTX's Other Non-Current Liabilities in the three quarters before Q2 2022 was $187,000 (Q1 2022), $329,000 (Q4 2021) and $295,000 (Q3 2021).
Peer Set

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr)
1 Johnson & Johnson 638.12 Bn 556.64 Bn 17.26 Bn
2 AbbVie 462.60 Bn 435.75 Bn 12.70 Bn
3 Merck 358.70 Bn 313.13 Bn 12.21 Bn
4 Novartis Ag 272.16 Bn 228.03 Bn 11.24 Bn
5 Astrazeneca 250.36 Bn 223.92 Bn 12.86 Bn
6 Amgen 227.87 Bn 183.27 Bn 7.24 Bn
7 Gilead Sciences 184.97 Bn 159.08 Bn 6.22 Bn
8 Pfizer 162.61 Bn 109.56 Bn 10.94 Bn
9 Vertex Pharmaceuticals 132.45 Bn 104.46 Bn 2.84 Bn
10 Edgewise Therapeutics 4.38 Bn 4.38 Bn -
Historic Data

Historic Data

Download Data
DateValue
Jun 30, 2022 192,000.00
Mar 31, 2022 187,000.00
Dec 31, 2021 329,000.00
Sep 30, 2021 295,000.00
API Access

Edgewise Therapeutics Other Non-Current Liabilities API

Pull this series into your own models, spreadsheets and apps with the Business Quant Historical Metrics API. The request below matches the chart above — change the frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.

https://data.businessquant.com/historic?slug=other-non-current-liabilities&ticker=EWTX&period=max&api_key=YOUR_API_KEY